You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 296 No. 4, July 26, 2006 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Commentary
 This Article
 •Full text
 •PDF
 •CME Course for This Article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (7)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA

CLINICIAN'S CORNER
Hyperthermic Biology and Cancer Therapies

A Hypothesis for the "Lance Armstrong Effect"

Donald S. Coffey, PhD; Robert H. Getzenberg, PhD; Theodore L. DeWeese, MD

JAMA. 2006;296:445-448.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

There is perhaps no more important question in cancer research than to understand the molecular basis of how the majority of patients with testicular cancer can be treated so effectively. For instance, how could Lance Armstrong, who was diagnosed with very advanced metastatic testicular cancer, be treated so successfully that he could subsequently win multiple grueling Tours de France? Although such therapeutic success is now common for many patients with this type of advanced testicular cancer, this type of outcome is unattainable for the majority of patients with other types of advanced solid tumors. What accounts for the astounding therapeutic success with testicular cancer, and can this outcome be explained both at the cellular and molecular levels? Understanding the basis for the "Lance Armstrong effect" may provide therapeutic targets to enhance cures of other common advanced . . . [Full Text of this Article]

Cancer Cells and Hyperthermia

Author Affiliations: Departments of Urology (Drs Coffey and Getzenberg), Radiation Oncology and Molecular Radiation Sciences (Dr DeWeese), and the Sidney Kimmel Comprehensive Cancer Center (Drs Coffey, Getzenberg, and DeWeese), Johns Hopkins University School of Medicine, Baltimore, Md.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Mechanism and uses of a membrane peptide that targets tumors and other acidic tissues in vivo
Andreev et al.
Proc. Natl. Acad. Sci. USA 2007;104:7893-7898.
ABSTRACT | FULL TEXT  

Novel Chemical Enhancers of Heat Shock Increase Thermal Radiosensitization through a Mitotic Catastrophe Pathway
Sekhar et al.
Cancer Res. 2007;67:695-701.
ABSTRACT | FULL TEXT  

What's new in the other general journals.
Tonks
BMJ 2006;333:295-296.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.